Source: Insightcare By Harsha Rajasimha, PhD, Founder and CEO, Jeeva Clinical Trials Inc. www.jeevatrials.com To say that COVID-19 has been a challenge to healthcare systems
The COVID-19 pandemic brought a new sense of appreciation for clinical trials as masses watched clinical trials closely while pharmaceutical companies raced against the clock
Source: MarketScale Clinical trials can save lives and provide new ways to treat disease. The industry estimates that 85% of all clinical trials face delays
The loss of his daughter to a rare congenital disorder in the United States and the passing of his younger brother in India from complications
The growing use of decentralized clinical trials has raised serious concerns regarding verification of patient comprehension and proper informed consent. The solution, says Dr. Harsha
Source: Healthcare Weekly Almost everything went online due to the COVID-19 pandemic, from remote collaboration with coworkers to ordering groceries and conducting online classes. But
Source: Clinical Trials Arena Diversity is a growing concern in all aspects of modern life, but the ramifications of this disparity in health care can
MANASSAS, VA. (PRWEB) DECEMBER 01, 2021 The ongoing COVID-19 pandemic ranks as perhaps the most serious global health crisis of the past hundred years. Worldwide,
Source: Relias Media IRBs are seeing a surge in study protocols that include remote recruitment, consent, and participation, raising ethical and regulatory considerations for investigators.
Source: HR.com Serious inefficiencies are hampering clinical trials of new drugs and treatments, prolonging the suffering of millions. Today’s platform technologies, says Dr. Harsha Rajasimha
Jeeva Clinical Trials Inc.
